Back

IgG N-glycosylation as a novel biomarker for immune checkpoint inhibitor-associated myocarditis: a comparative glycomic study

28 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Immune checkpoint inhibitor cardiotoxicity: mechanisms, biomarkers, and early cardiovascular injury Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jingyi Li

Peking Union Medical College Hospital, Beijing (China)

7 More presentations in this session

Presentation thumbnail
E3 ubiquitin ligase TRIM47 drives endothelial dysfunction in immune checkpoint inhibitor-associated myocarditis via K48-linked polyubiquitination and degradation of SCO1
Mr R. Gui (CN)
Abstract Slides Video
Presentation thumbnail
Neutrophils contribute to αPD1-induced latent myocardial injury via NET/NETosis axis: exploration of potential patho-mechanism, diagnostic biomarkers and therapeutic targets in ICIs-associated myocard
Miss Y. Chen (Xiamen, CN)
Abstract Slides Video
Presentation thumbnail
Assessment of coronary artery calcification progression on standard non-gated CT scans in melanoma patients treated with immune checkpoint inhibitors
Doctor N. Laachir (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Real-world cardiovascular toxicity of immune checkpoint inhibitors in an asian population: insights from a nationwide taiwanese registry
Doctor K. Chen (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Myocardial deformation, myocardial work and vascular biomarkers for the assessement of patients treated with immune checkpoint inhibitors
Doctor K. Katogiannis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Immune checkpoint inhibitor cardiotoxicity: mechanisms, biomarkers, and early cardiovascular injury

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Pathological spectrum of immune checkpoint myocarditis: The fast track ICI cohort study
21 June 2025
thumbnail
Congress Presentation
Upfront immune checkpoint inhibitors and long-term risk of major adverse cardiovascular events: a population-based propensity-matched cohort study
28 August 2026
thumbnail
Congress Presentation
Key immune related genes and potential therapeutic targets in immune checkpoint inhibitor associated myocarditis: a new fing
29 August 2025
thumbnail
Congress Presentation
Biomarker research in Circulation
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources